Franklin Biotechnology Discovery Fund Class A (FBDIX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
174.61
-0.50 (-0.29%)
At close: Mar 6, 2026
Fund Assets1.04B
Expense Ratio1.05%
Min. Investment$1,000
Turnover21.87%
Dividend (ttm)17.92
Dividend Yield10.23%
Dividend Growth52.36%
Payout Frequencyn/a
Ex-Dividend DateDec 22, 2025
Previous Close175.11
YTD Return-0.44%
1-Year Return49.30%
5-Year Return36.68%
52-Week Low95.30
52-Week High183.12
Beta (5Y)n/a
Holdings92
Inception DateSep 15, 1997

About FBDIX

Franklin Biotechnology Discovery Fund Class A is a mutual fund that seeks capital appreciation by investing at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund focuses on companies involved in genomics, genetic engineering, gene therapy, pharmaceuticals, and related health care sectors. With a portfolio heavily weighted toward biotechnology and pharmaceutical industries, the fund aims to capitalize on innovations in cell and gene therapies, specialty drugs for rare diseases, and advanced treatment platforms. The fund maintains a diversified approach across approximately 80 biotechnology and pharmaceutical issuers, providing exposure to the evolving landscape of medical breakthroughs and therapeutic advancements. Managed by an experienced team since its inception, the fund distributes dividends annually and is designed for investors seeking long-term growth through participation in the biotechnology and life sciences sectors.

Fund Family Franklin Templeton Investments
Category Health
Performance Rating Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol FBDIX
Share Class Class A
Index NASDAQ Biotechnology CR

Performance

FBDIX had a total return of 49.30% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.12%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
FRBRXClass R60.69%
FTDZXAdvisor Class0.80%
FBTDXClass C1.80%

Top 10 Holdings

40.30% of assets
NameSymbolWeight
Gilead Sciences, Inc.GILD6.17%
Amgen Inc.AMGN4.81%
Vertex Pharmaceuticals IncorporatedVRTX4.71%
Jazz Pharmaceuticals plcJAZZ4.56%
Regeneron Pharmaceuticals, Inc.REGN4.44%
argenx SEARGX4.03%
Praxis Precision Medicines, Inc.PRAX3.02%
Insmed IncorporatedINSM2.90%
Ascendis Pharma A/SASND2.88%
Guardant Health, Inc.GH2.78%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 22, 2025$17.9181Dec 22, 2025
Dec 20, 2024$11.7607Dec 20, 2024
Dec 20, 2022$0.1411Dec 20, 2022
Dec 15, 2021$17.6831Dec 15, 2021
Dec 15, 2020$10.3921Dec 15, 2020
Dec 16, 2019$14.1643Dec 18, 2019
Full Dividend History